Physical Stability of Proteins in Aqueous Solution: Mechanism and Driving Forces in Nonnative Protein Aggregation

Irreversible protein aggregation is problematic in the biotechnology industry, where aggregation is encountered throughout the lifetime of a therapeutic protein, including during refolding, purification, sterilization, shipping, and storage processes. The purpose of the current review is to provide a fundamental understanding of the mechanisms by which proteins aggregate and by which varying solution conditions, such as temperature, pH, salt type, salt concentration, cosolutes, preservatives, and surfactants, affect this process.

[1]  Ank Valstar Protein-surfactant interactions , 2000 .

[2]  Henry Eyring,et al.  Conformation Changes of Proteins , 1954 .

[3]  T. Arakawa,et al.  Mechanism of protein salting in and salting out by divalent cation salts: balance between hydration and salt binding. , 1984, Biochemistry.

[4]  G. Visor,et al.  Stability of interleukin 1 beta (IL-1 beta) in aqueous solution: analytical methods, kinetics, products, and solution formulation implications. , 1991, Pharmaceutical research.

[5]  Steven J. Prestrelski,et al.  A New Strategy for Enhancing the Stability of Lyophilized Protein: The Effect of the Reconstitution Medium on Keratinocyte Growth Factor , 1995, Pharmaceutical Research.

[6]  F. Gejyo,et al.  Kinetic analysis of amyloid fibril formation. , 1999, Methods in enzymology.

[7]  A. Grillo,et al.  Conformational origin of the aggregation of recombinant human factor VIII. , 2001, Biochemistry.

[8]  C. Dobson,et al.  A kinetic study of β‐lactoglobulin amyloid fibril formation promoted by urea , 2002 .

[9]  B. Kerwin,et al.  Effects of Tween 80 and Sucrose on Acute Short-Term Stability and Long-Term Storage at − 20 C of a Recombinant Hemoglobin , 1998 .

[10]  T. Arakawa,et al.  Stability of recombinant consensus interferon to air-jet and ultrasonic nebulization. , 1995, Journal of pharmaceutical sciences.

[11]  S. Magdassi Surface activity of proteins : chemical and physicochemical modifications , 1996 .

[12]  J. Prausnitz,et al.  Protein-protein interactions in concentrated electrolyte solutions: Hofmeister-series effects , 2002 .

[13]  A. Randolph,et al.  Theory of Particulate Processes: Analysis and Techniques of Continuous Crystallization , 1971 .

[14]  C. Pace,et al.  Forces contributing to the conformational stability of proteins , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  Calculation of phase diagrams for aqueous protein solutions , 2001 .

[16]  P. Privalov,et al.  Stability of protein structure and hydrophobic interaction. , 1988, Advances in protein chemistry.

[17]  P. Deluca,et al.  Stability of ribonuclease A in solution and the freeze-dried state. , 1990, Journal of pharmaceutical sciences.

[18]  M. Betenbaugh,et al.  I. Study of protein aggregation due to heat denaturation: A structural approach using circular dichroism spectroscopy, nuclear magnetic resonance, and static light scattering. , 1998, Biotechnology and bioengineering.

[19]  T. Arakawa,et al.  Stabilization of protein structure by sugars. , 1982, Biochemistry.

[20]  C. Ionescu-Zanetti,et al.  Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates. , 2001, Biochemistry.

[21]  P E Fraser,et al.  A kinetic model for amyloid formation in the prion diseases: importance of seeding. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[22]  T. Arakawa,et al.  Strategies to suppress aggregation of recombinant keratinocyte growth factor during liquid formulation development. , 1994, Journal of pharmaceutical sciences.

[23]  Pablo G. Debenedetti,et al.  Metastable Liquids: Concepts and Principles , 1996 .

[24]  K. Dill Dominant forces in protein folding. , 1990, Biochemistry.

[25]  V. Uversky,et al.  Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. , 2001, Biochemistry.

[26]  J. King,et al.  Conformation of P22 tailspike folding and aggregation intermediates probed by monoclonal antibodies , 1997, Protein science : a publication of the Protein Society.

[27]  Jan Drenth,et al.  Understanding protein crystallization on the basis of the phase diagram , 1999 .

[28]  D. Paton,et al.  Thermodynamic characterization of an intermediate state of human growth hormone , 1998, Protein science : a publication of the Protein Society.

[29]  B. Chang,et al.  Preferential exclusion of sucrose from recombinant interleukin-1 receptor antagonist: role in restricted conformational mobility and compaction of native state. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Carrotta,et al.  Conformational characterization of oligomeric intermediates and aggregates in β‐lactoglobulin heat aggregation , 2001, Protein science : a publication of the Protein Society.

[31]  C. R. Middaugh,et al.  Stabilization of proteins by low molecular weight multi-ions. , 2002, Journal of pharmaceutical sciences.

[32]  Carlos S. Moreno,et al.  Carboxymethylation of the PP2A Catalytic Subunit inSaccharomyces cerevisiae Is Required for Efficient Interaction with the B-type Subunits Cdc55p and Rts1p* , 2001, The Journal of Biological Chemistry.

[33]  J. King,et al.  Thermolabile folding intermediates: inclusion body precursors and chaperonin substrates , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  Theodore W Randolph,et al.  Oxidative dimer formation is the critical rate-limiting step for Parkinson's disease alpha-synuclein fibrillogenesis. , 2003, Biochemistry.

[35]  M. Manning,et al.  Aggregation of recombinant human interferon gamma: kinetics and structural transitions. , 1998, Journal of pharmaceutical sciences.

[36]  M. Manning,et al.  Chemical and physical pathways of protein degradation , 1992 .

[37]  J. Carpenter,et al.  A transient expansion of the native state precedes aggregation of recombinant human interferon-gamma. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[38]  M. Mulkerrin,et al.  pH dependence of the reversible and irreversible thermal denaturation of gamma interferons. , 1989, Biochemistry.

[39]  Theodore W Randolph,et al.  Roles of conformational stability and colloidal stability in the aggregation of recombinant human granulocyte colony‐stimulating factor , 2003, Protein science : a publication of the Protein Society.

[40]  A. Fink,et al.  Classification of acid denaturation of proteins: intermediates and unfolded states. , 1994, Biochemistry.

[41]  S. Shire,et al.  Stability and characterization of recombinant human relaxin. , 1996, Pharmaceutical biotechnology.

[42]  D. Hallén,et al.  Solvent Effects on the Solubility and Physical Stability of Human Insulin-Like Growth Factor I , 1997, Pharmaceutical Research.

[43]  T. Arakawa,et al.  Mechanism of protein precipitation and stabilization by co-solvents , 1988 .

[44]  T. Österberg,et al.  Recombinant factor VIII SQ—influence of oxygen, metal ions, pH and ionic strength on its stability in aqueous solution , 1997 .

[45]  Michael Farnum,et al.  Effect of glycerol on the interactions and solubility of bovine pancreatic trypsin inhibitor. , 1999, Biophysical journal.

[46]  D. Erie,et al.  Interpreting the effects of small uncharged solutes on protein-folding equilibria. , 2001, Annual review of biophysics and biomolecular structure.

[47]  M. Yu,et al.  Folding pathway of human alpha 1-antitrypsin: characterization of an intermediate that is active but prone to aggregation. , 1996, Biochemical and biophysical research communications.

[48]  A. Arabshahi,et al.  [6] Second virial coefficient as predictor in protein crystal growth. , 1997, Methods in enzymology.

[49]  Ronald Wetzel,et al.  Amyloid-like features of polyglutamine aggregates and their assembly kinetics. , 2002, Biochemistry.

[50]  Wayne R. Gombotz,et al.  Interleukin-1 Receptor (IL-1R) Liquid Formulation Development Using Differential Scanning Calorimetry , 1998, Pharmaceutical Research.

[51]  M. Hora,et al.  Solubility of recombinant human tissue factor pathway inhibitor. , 1999, Journal of Pharmacy and Science.

[52]  R. Borchardt,et al.  Stability of Protein Pharmaceuticals , 1989, Pharmaceutical Research.

[53]  A. Fink Protein aggregation: folding aggregates, inclusion bodies and amyloid. , 1998, Folding & design.

[54]  J. Carpenter,et al.  A new mechanism for decreasing aggregation of recombinant human interferon-gamma by a surfactant: slowed dissolution of lyophilized formulations in a solution containing 0.03% polysorbate 20. , 2002, Journal of pharmaceutical sciences.

[55]  Theodore W Randolph,et al.  Aggregation of granulocyte colony stimulating factor under physiological conditions: characterization and thermodynamic inhibition. , 2002, Biochemistry.

[56]  T. Randolph,et al.  Molten Globule Intermediate of Recombinant Human Growth Hormone: Stabilization with Surfactants , 1996, Biotechnology progress.

[57]  K. Dill,et al.  A View of the Hydrophobic Effect , 2002 .

[58]  G. Visor,et al.  Stability of Interleukin 1β (IL-1β) in Aqueous Solution: Analytical Methods, Kinetics, Products, and Solution Formulation Implications , 1991, Pharmaceutical Research.

[59]  J L Cleland,et al.  Tween protects recombinant human growth hormone against agitation-induced damage via hydrophobic interactions. , 1998, Journal of pharmaceutical sciences.

[60]  C. Dobson,et al.  A kinetic study of beta-lactoglobulin amyloid fibril formation promoted by urea. , 2002, Protein science : a publication of the Protein Society.

[61]  O. Velev,et al.  Protein interactions in solution characterized by light and neutron scattering: comparison of lysozyme and chymotrypsinogen. , 1998, Biophysical journal.

[62]  J L Cleland,et al.  The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation. , 1993, Critical reviews in therapeutic drug carrier systems.

[63]  B. Kerwin,et al.  Effects of Tween 80 and sucrose on acute short-term stability and long-term storage at -20 degrees C of a recombinant hemoglobin. , 1998, Journal of pharmaceutical sciences.

[64]  J. Lee,et al.  The stabilization of proteins by sucrose. , 1981, The Journal of biological chemistry.

[65]  T. Randolph,et al.  Surfactant-Stabilized Protein Formulations: A Review of Protein-Surfactant Interactions and Novel Analytical Methodologies , 1997 .

[66]  P. Privalov,et al.  Cold Denaturation of Protein , 1990 .

[67]  A George,et al.  Predicting protein crystallization from a dilute solution property. , 1994, Acta crystallographica. Section D, Biological crystallography.

[68]  Chung C. Hsu,et al.  Aggregation of recombinant human growth hormone induced by phenolic compounds , 1996 .

[69]  I. Apostol,et al.  Acute and long-term stability studies of deoxy hemoglobin and characterization of ascorbate-induced modifications. , 1999, Journal of pharmaceutical sciences.

[70]  C. Dobson,et al.  Dependence on solution conditions of aggregation and amyloid formation by an SH3 domain. , 2001, Journal of molecular biology.

[71]  Zamora,et al.  Phase behavior of small attractive colloidal particles. , 1996, Physical review letters.

[72]  Hydration as a major factor in preferential solvent-protein interactions , 2002 .

[73]  Charles F. Morris,et al.  Aggregation Pathway of Recombinant Human Keratinocyte Growth Factor and Its Stabilization , 1994, Pharmaceutical Research.

[74]  Theodore W Randolph,et al.  Surfactant-protein interactions. , 2002, Pharmaceutical biotechnology.

[75]  John F. Carpenter,et al.  Thermal Stability of Low Molecular Weight Urokinase During Heat Treatment. II. Effect of Polymeric Additives , 1994, Pharmaceutical Research.

[76]  J. Carpenter,et al.  Partial molar volume, surface area, and hydration changes for equilibrium unfolding and formation of aggregation transition state: High-pressure and cosolute studies on recombinant human IFN-γ , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[77]  Y. Yamagata,et al.  Contribution of salt bridges near the surface of a protein to the conformational stability. , 2000, Biochemistry.

[78]  R. Jaenicke,et al.  Protein folding: local structures, domains, subunits, and assemblies. , 1991, Biochemistry.

[79]  B. Cunningham,et al.  Dimerization of human growth hormone by zinc. , 1991, Science.

[80]  J. M. Sanchez-Ruiz,et al.  Theoretical analysis of Lumry-Eyring models in differential scanning calorimetry. , 1992, Biophysical journal.

[81]  A. D. Robertson,et al.  Effects of a naturally occurring compatible osmolyte on the internal dynamics of ribonuclease A. , 1995, Biochemistry.

[82]  W. Gombotz,et al.  Minimization of recombinant human Flt3 ligand aggregation at the Tm plateau: a matter of thermal reversibility. , 1999, Biochemistry.

[83]  M. Manning,et al.  Thermodynamic Modulation of Light Chain Amyloid Fibril Formation* , 2000, The Journal of Biological Chemistry.

[84]  N. Elvassore,et al.  Forces between aqueous nonuniformly charged colloids from molecular simulation , 2002 .

[85]  C. Pace,et al.  Polar group burial contributes more to protein stability than nonpolar group burial. , 2001, Biochemistry.

[86]  Kevin L. Shaw,et al.  Increasing protein stability by altering long‐range coulombic interactions , 1999, Protein science : a publication of the Protein Society.

[87]  R. Sousa Use of glycerol, polyols and other protein structure stabilizing agents in protein crystallization. , 1995, Acta crystallographica. Section D, Biological crystallography.

[88]  J. Friedman,et al.  Time-resolved resonance Raman spectroscopy as probe of structure, dynamics, and reactivity in hemoglobin. , 1994, Methods in enzymology.

[89]  T. Patapoff,et al.  The Effect of Benzyl Alcohol on Recombinant Human Interferon-γ , 1997, Pharmaceutical Research.

[90]  C. Russell Middaugh,et al.  Formulation Design of Acidic Fibroblast Growth Factor , 1993, Pharmaceutical Research.

[91]  Charles F. Zukoski,et al.  Protein interactions and crystallization , 1996 .

[92]  W. William Wilson,et al.  Relation between the solubility of proteins in aqueous solutions and the second virial coefficient of the solution , 1999 .

[93]  G. Barone,et al.  A reassessment of the molecular origin of cold denaturation. , 1997, Journal of biochemistry.

[94]  M. Manning,et al.  Counteracting Effects of Renal Solutes on Amyloid Fibril Formation by Immunoglobulin Light Chains* , 2001, The Journal of Biological Chemistry.

[95]  S. Allison,et al.  Infrared spectroscopic studies of lyophilization- and temperature-induced protein aggregation. , 1995, Journal of pharmaceutical sciences.

[96]  J. Edsall Hsien Wu and the First Theory of Protein Denaturation (1931) , 1995 .

[97]  M. Betenbaugh,et al.  II. Electrostatic effect in the aggregation of heat-denatured RNase A and implications for protein additive design. , 1998, Biotechnology and bioengineering.

[98]  A. Klibanov,et al.  On the role of reversible denaturation (unfolding) in the irreversible thermal inactivation of enzymes , 1983, Biotechnology and bioengineering.

[99]  C. Dobson,et al.  Unfolding and aggregation during the thermal denaturation of streptokinase. , 2002, European journal of biochemistry.

[100]  K. Aoki,et al.  Differential scanning calorimetric studies on bovine serum albumin: II. Effects of neutral salts and urea. , 1991, International journal of biological macromolecules.

[101]  M C Manning,et al.  Inhibition of stress-induced aggregation of protein therapeutics. , 1999, Methods in enzymology.

[102]  A. Rosenberg,et al.  Structure dynamics of proteins by hydrogen exchange methods. , 1980, Biophysical Journal.

[103]  E. Landau,et al.  The Hofmeister series: salt and solvent effects on interfacial phenomena , 1997, Quarterly Reviews of Biophysics.

[104]  A. Gittis,et al.  Protein crystallization by design: chymotrypsinogen without precipitants. , 2000, Journal of molecular biology.

[105]  T. Arakawa,et al.  Stabilization of recombinant human keratinocyte growth factor by osmolytes and salts. , 1996, Journal of pharmaceutical sciences.

[106]  V. Uversky,et al.  Effect of salts on the stability and folding of staphylococcal nuclease. , 2001, Biochemistry.

[107]  U. Chatterjee,et al.  Effect of unconventional feeds on production cost, growth performance and expression of quantitative genes in growing pigs , 2022, Journal of the Indonesian Tropical Animal Agriculture.

[108]  W. William Wilson,et al.  Correlation of second virial coefficients and solubilities useful in protein crystal growth , 1999 .

[109]  S. N. Timasheff,et al.  Control of protein stability and reactions by weakly interacting cosolvents: the simplicity of the complicated. , 1998, Advances in protein chemistry.